InvestorsHub Logo
Followers 43
Posts 3041
Boards Moderated 1
Alias Born 08/09/2006

Re: lefty18 post# 631

Friday, 01/26/2007 8:42:05 AM

Friday, January 26, 2007 8:42:05 AM

Post# of 2378
When you connect all of the dots here, you get a very pretty picture.

1. As early as the mid-90s Dr. Sidransky's group discusses the possibility of detecting a universal screening test for cancer.

2. In '03 they're researching a method to detect both head and neck and lung cancer simultaneously.

3. In a recent study they reveal a test that detected lung cancer in a man a year before it was dianosed by current methods.

4. The professional connections include current FDA director Dr. Andrew Von Eschenbach, whom he wrote papers and conducted research with.

5. He recently served on the board of directors at Imclone with Carl Icahn, who is a major investor in biotech (particularly imclone).

6. He served on a scientific board with current presidential candidate Tommy Thompson.

I think that the R&D phase of Champions Biotechnology has been carried out over the last 15 years. They're now ready to commercialize a product (or products) and go public.


Only the beginning.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CSBR News